Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 37
Filtrar
1.
Ann Fam Med ; 15(1): 23-36, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-28376458

RESUMO

PURPOSE: Our aim was to update estimates of the health and economic impact of clinical services recommended for the primary prevention of cardiovascular disease (CVD) for the comparative rankings of the National Commission on Prevention Priorities, and to explore differences in outcomes by sex and race/ethnicity. METHODS: We used a single, integrated, microsimulation model to generate comparable results for 3 services recommended by the US Preventive Services Task Force: aspirin counseling for the primary prevention of CVD and colorectal cancer, screening and treatment for lipid disorders (usually high cholesterol), and screening and treatment for hypertension. Analyses compare lifetime outcomes from the societal perspective for a US-representative birth cohort of 100,000 persons with and without access to each clinical preventive service. Primary outcomes are health impact, measured by the net difference in lifetime quality-adjusted life years (QALYs), and cost-effectiveness, measured in incremental cost per QALY or cost savings per person in 2012 dollars. Results are also presented for population subgroups defined by sex and race/ethnicity. RESULTS: Health impact is highest for hypertension screening and treatment (15,600 QALYs), but is closely followed by cholesterol screening and treatment (14,300 QALYs). Aspirin counseling has a lower health impact (2,200 QALYs) but is found to be cost saving ($31 saved per person). Cost-effectiveness for cholesterol and hypertension screening and treatment is $33,800 per QALY and $48,500 per QALY, respectively. Findings favor hypertension over cholesterol screening and treatment for women, and opportunities to reduce disease burden across all services are greatest for the non-Hispanic black population. CONCLUSIONS: All 3 CVD preventive services continue to rank highly among other recommended preventive services for US adults, but individual priorities can be tailored in practice by taking a patient's demographic characteristics and clinical objectives into account.


Assuntos
Aspirina/uso terapêutico , Análise Custo-Benefício , Hipercolesterolemia/diagnóstico , Hipertensão/diagnóstico , Programas de Rastreamento/economia , Prevenção Primária/economia , Adolescente , Adulto , Idoso , Neoplasias Colorretais/diagnóstico , Aconselhamento , Etnicidade , Feminino , Humanos , Hipercolesterolemia/tratamento farmacológico , Hipertensão/tratamento farmacológico , Masculino , Pessoa de Meia-Idade , Anos de Vida Ajustados por Qualidade de Vida , Distribuição por Sexo , Estados Unidos , Adulto Jovem
2.
Ann Fam Med ; 15(1): 14-22, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-28376457

RESUMO

PURPOSE: The Patient Protection and Affordable Care Act's provisions for first-dollar coverage of evidence-based preventive services have reduced an important barrier to receipt of preventive care. Safety-net providers, however, still serve a substantial uninsured population, and clinician and patient time remain limited in all primary care settings. As a consequence, decision makers continue to set priorities to help focus their efforts. This report updates estimates of relative health impact and cost-effectiveness for evidence-based preventive services. METHODS: We assessed the potential impact of 28 evidence-based clinical preventive services in terms of their cost-effectiveness and clinically preventable burden, as measured by quality-adjusted life years (QALYs) saved. Each service received 1 to 5 points on each of the 2 measures-cost-effectiveness and clinically preventable burden-for a total score ranging from 2 to 10. New microsimulation models were used to provide updated estimates of 12 of these services. Priorities for improving delivery rates were established by comparing the ranking with what is known of current delivery rates nationally. RESULTS: The 3 highest-ranking services, each with a total score of 10, are immunizing children, counseling to prevent tobacco initiation among youth, and tobacco-use screening and brief intervention to encourage cessation among adults. Greatest population health improvement could be obtained from increasing utilization of clinical preventive services that address tobacco use, obesity-related behaviors, and alcohol misuse, as well as colorectal cancer screening and influenza vaccinations. CONCLUSIONS: This study identifies high-priority preventive services and should help decision makers select which services to emphasize in quality-improvement initiatives.


Assuntos
Prioridades em Saúde/economia , Programas de Rastreamento/economia , Serviços Preventivos de Saúde/economia , Adolescente , Adulto , Criança , Neoplasias Colorretais/prevenção & controle , Análise Custo-Benefício , Feminino , Humanos , Masculino , Obesidade/prevenção & controle , Patient Protection and Affordable Care Act , Anos de Vida Ajustados por Qualidade de Vida , Provedores de Redes de Segurança , Uso de Tabaco/prevenção & controle , Estados Unidos
3.
Ann Fam Med ; 15(1): 37-47, 2017 01.
Artigo em Inglês | MEDLINE | ID: mdl-28376459

RESUMO

PURPOSE: To help clinicians and care systems determine the priority for tobacco counseling in busy clinic schedules, we assessed the lifetime health and economic value of annually counseling youth to discourage smoking initiation and of annually counseling adults to encourage cessation. METHODS: We conducted a microsimulation analysis to estimate the health impact and cost effectiveness of both types of tobacco counseling in a US birth cohort of 4,000,000. The model used for the analysis was constructed from nationally representative data sets and structured literature reviews. RESULTS: Compared with no tobacco counseling, the model predicts that annual counseling for youth would reduce the average prevalence of smoking cigarettes during adult years by 2.0 percentage points, whereas annual counseling for adults will reduce prevalence by 3.8 percentage points. Youth counseling would prevent 42,686 smoking-attributable fatalities and increase quality-adjusted life years (QALYs) by 756,601 over the lifetime of the cohort. Adult counseling would prevent 69,901 smoking-attributable fatalities and increase QALYs by 1,044,392. Youth and adult counseling would yield net savings of $225 and $580 per person, respectively. If annual tobacco counseling was provided to the cohort during both youth and adult years, then adult smoking prevalence would be 5.5 percentage points lower compared with no counseling, and there would be 105,917 fewer smoking-attributable fatalities over their lifetimes. Only one-third of the potential health and economic benefits of counseling are being realized at current counseling rates. CONCLUSIONS: Brief tobacco counseling provides substantial health benefits while producing cost savings. Both youth and adult intervention are high-priority uses of limited clinician time.


Assuntos
Análise Custo-Benefício , Aconselhamento/economia , Prevenção do Hábito de Fumar , Fumar/terapia , Adulto , Distribuição por Idade , Feminino , Humanos , Masculino , Anos de Vida Ajustados por Qualidade de Vida , Sensibilidade e Especificidade , Abandono do Hábito de Fumar/métodos , Estados Unidos , Adulto Jovem
4.
Ann Intern Med ; 164(12): 777-86, 2016 06 21.
Artigo em Inglês | MEDLINE | ID: mdl-27064573

RESUMO

BACKGROUND: Evidence indicates that aspirin is effective for the primary prevention of cardiovascular disease (CVD) and colorectal cancer (CRC) but also increases the risk for gastrointestinal (GI) and cerebral hemorrhages. OBJECTIVE: To assess the net balance of benefits and harms from routine aspirin use across clinically relevant age, sex, and CVD risk groups. DESIGN: Decision analysis using a microsimulation model. DATA SOURCES: 3 systematic evidence reviews. TARGET POPULATION: Men and women aged 40 to 79 years with a 10-year CVD risk of 20% or less, and no history of CVD and without elevated risk for GI or cerebral hemorrhages that would contraindicate aspirin use. TIME HORIZON: Lifetime, 20 years, and 10 years. PERSPECTIVE: Clinical. INTERVENTION: Low-dose aspirin (≤100 mg/d). OUTCOME MEASURES: Primary outcomes are length and quality of life measured in net life-years and quality-adjusted life-years. Benefits include reduced nonfatal myocardial infarction, nonfatal ischemic stroke, fatal CVD, CRC incidence, and CRC mortality. Harms include increased fatal and nonfatal GI bleeding and hemorrhagic stroke. RESULTS OF BASE-CASE ANALYSIS: Lifetime net quality-adjusted life-years are positive for most adults initiating aspirin at ages 40 to 69 years, and life expectancy gains are expected for most men and women initiating aspirin at ages 40 to 59 years and 60 to 69 years with higher CVD risk. Harms may exceed benefits for persons starting aspirin in their 70s and for many during the first 10 to 20 years of use. RESULTS OF SENSITIVITY ANALYSIS: Results are most sensitive to the relative risk for hemorrhagic stroke and CVD mortality but are affected by all relative risk estimates, baseline GI bleeding incidence and case-fatality rates, and disutilities associated with aspirin use. LIMITATIONS: Aspirin effects by age are uncertain. Stroke benefits are conservatively estimated. Gastrointestinal bleeding incidence and case-fatality rates account only for age and sex. CONCLUSION: Lifetime aspirin use for primary prevention initiated at younger ages (40 to 69 years) and in persons with higher CVD risk shows the greatest potential for positive net benefit. PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.


Assuntos
Anticarcinógenos/uso terapêutico , Aspirina/uso terapêutico , Doenças Cardiovasculares/prevenção & controle , Neoplasias Colorretais/prevenção & controle , Técnicas de Apoio para a Decisão , Fibrinolíticos/uso terapêutico , Prevenção Primária , Adulto , Idoso , Anticarcinógenos/administração & dosagem , Anticarcinógenos/efeitos adversos , Aspirina/administração & dosagem , Aspirina/efeitos adversos , Feminino , Fibrinolíticos/administração & dosagem , Fibrinolíticos/efeitos adversos , Hemorragia Gastrointestinal/induzido quimicamente , Humanos , Masculino , Pessoa de Meia-Idade , Anos de Vida Ajustados por Qualidade de Vida , Medição de Risco , Acidente Vascular Cerebral/induzido quimicamente
5.
Prev Chronic Dis ; 10: E25, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23428084

RESUMO

The objective of this study was to determine the effect of a price reduction on salad bar purchases in a corporate cafeteria. We reduced the price of salad bar purchases by 50% during March 2012 and analyzed sales data by month for February through June 2012. We also conducted an anonymous survey. Salad bar sales by weight more than tripled during the price reduction and returned to baseline afterward. Survey respondents reported that the high price of salad relative to other choices is a barrier to purchases. Policies that make the price of salads equal to other choices in cafeterias may significantly increase healthful food consumption.


Assuntos
Serviços de Alimentação/normas , Corporações Profissionais , Verduras/economia , Custos e Análise de Custo , Humanos , Cultura Organizacional
6.
Med Care ; 50(8): 676-84, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22710277

RESUMO

OBJECTIVE: To examine the relationship between primary care medical home clinical practice systems corresponding to the domains of the Chronic Care Model and annual diabetes-related health care costs incurred by members of a health plan with type-2 diabetes and receiving care at one of 27 Minnesota-based medical groups. STUDY DESIGN: Cross-sectional analysis of the relation between patient-level costs and Patient-Centered Medical Home (PCMH) practice systems as measured by the Physician Practice Connections Readiness Survey. METHODS: Multivariate regressions adjusting for patient demographics, health status, and comorbidities estimated the relationship between the use of PCMH clinical practice systems and 3 annual cost outcomes: total costs of diabetes-related care, outpatient medical costs of diabetes-related care, and inpatient costs of diabetes-related care (ie, inpatient and emergency care). RESULTS: Overall PCMH scores were not significantly related to any annual cost outcome; however, 2 of 5 subdomains were related. Health Care Organization scores were related to significantly lower total (P=0.04) and inpatient costs (P=0.03). Clinical Decision Support was marginally related to a lower total cost (P=0.06) and significantly related to lower inpatient costs (P=0.02). A detailed analysis of the Health Care Organization domain showed that compared with medical groups with only quality improvement, those with performance measurement and individual provider feedback averaged $245/patient less. Medical groups with clinical reminders for counseling averaged $338/patient less. CONCLUSIONS: Certain PCMH practice systems were related to lower costs, but these effects are small compared with total costs. Further research about how these and other PCMH domains affect costs over time is needed.


Assuntos
Diabetes Mellitus Tipo 2/economia , Gastos em Saúde/estatística & dados numéricos , Assistência Centrada no Paciente/organização & administração , Adulto , Fatores Etários , Idoso , Comorbidade , Estudos Transversais , Feminino , Custos de Cuidados de Saúde/estatística & dados numéricos , Serviços de Saúde/economia , Serviços de Saúde/estatística & dados numéricos , Humanos , Pacientes Internados/estatística & dados numéricos , Masculino , Pessoa de Meia-Idade , Pacientes Ambulatoriais/estatística & dados numéricos , Assistência Centrada no Paciente/economia , Fatores Sexuais , Adulto Jovem
7.
Ann Fam Med ; 9(6): 515-21, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-22084262

RESUMO

PURPOSE We describe changes over time in performance on measures of technical quality and patient experience as a group of primary care clinics transformed themselves into level III patient-centered medical homes. METHODS A group of 21 Minnesota primary care clinics achieving level III recognition as medical homes by the National Committee for Quality Assurance has been tracking a variety of quality and patient satisfaction measures for years. We analyzed trends in these measures and compared them with those of other medical groups in the community to estimate what we might expect as other primary care sites gear up to achieve medical home status. RESULTS The clinics in this group achieved a 1% to 3% increase per year in patient satisfaction and a 2% to 7% increase per year in performance on quality measures for diabetes, coronary artery disease, preventive services, and generic medication use. When compared with the average for other medical groups in the region, the rates of increase were greater for satisfaction, but similar for the quality measures. CONCLUSIONS Achieving medical home recognition was associated with improvements in quality and patient satisfaction for these clinics, but the rate of improvement is slow and does not always exceed levels in the surrounding community in Minnesota (which are also improving). Expectations for large and rapid change are probably unrealistic.


Assuntos
Satisfação do Paciente/estatística & dados numéricos , Assistência Centrada no Paciente/normas , Atenção Primária à Saúde/normas , Melhoria de Qualidade/tendências , Indicadores de Qualidade em Assistência à Saúde/tendências , Adolescente , Adulto , Idoso , Feminino , Pesquisas sobre Atenção à Saúde , Humanos , Masculino , Pessoa de Meia-Idade , Minnesota , Assistência Centrada no Paciente/tendências , Atenção Primária à Saúde/tendências , Fatores de Tempo , Adulto Jovem
8.
J Emerg Med ; 39(5): 662-8, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-19959319

RESUMO

BACKGROUND: Quality educators are a core component of successful residency training. A structured, consistent, validated evaluation of clinical educators is important to improve teaching aptitude, further faculty development, and improve patient care. STUDY OBJECTIVES: The authors sought to identify specific domains of instructional quality and to develop a composite instrument for assessing instructional quality. METHODS: The study setting is a 3-year residency program. Residents rated the quality of faculty member instruction using an 18-item survey twice over a 2-year period (2004-2005). Each survey item used a 9-point scale. Factor analysis employing a Varimax rotation identified domains of instructional performance. Cronbach's alpha was used to assess the internal consistency of the identified domains. RESULTS: There were 29 faculty members evaluated. Using 2004 data, five domains of instructional quality were identified that explained 92.5% of the variation in survey responses (χ(2) = 2.33, P = 0.11). These were: Competency and Professionalism (30% of variation), Commitment to Knowledge and Instruction (23%), Inclusion and Interaction (17%), Patient Focus (13%), and Openness to Ideas (9%). Competency and Professionalism included appropriate care, effective patient communication, use of new techniques, and ethical principles. Commitment to Knowledge and Instruction included research, mentoring, feedback, and availability. Inclusion and Interaction included procedural participation and bedside teaching. Patient Focus included compassion, effective care, and sensitivity to diverse populations. Openness to Ideas included enthusiasm and receptivity of new ideas. These five domains were consistent in the 2005 data (Cronbach's alpha 0.68-0.75). CONCLUSIONS: A five-domain instrument consistently accounted for variations in faculty teaching performance as rated by resident physicians. This instrument may be useful for standardized assessment of instructional quality.


Assuntos
Medicina de Emergência/educação , Docentes de Medicina/normas , Internato e Residência , Análise Fatorial , Humanos , Internato e Residência/organização & administração , Liderança
9.
J Addict Dis ; 38(3): 301-310, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32378481

RESUMO

Background: Opioid overdose is a national health priority and curbing inappropriate prescribing is critical. In 2016, the Centers for Disease Control and Prevention (CDC) issued appropriate prescribing guidelines.Objectives: Examine associations between care networks defined by shared patients and problematic opioid prescribing.Methods: Analysis was at the provider-year level. Social network analysis (SNA) applied to the Medicaid MarketScan® Research Database for the years 2010-2015 identified care communities, each community's level of integration (centralization), and each provider's integration (centrality). Nested multivariable logistic regressions controlling for patient mix and provider specialty simultaneously examined the risk of any (incident) and repeated (prevalent) inappropriate prescribing.Outcomes: Four behaviors defined by the CDC guidelines were examined: (1) more than 90 days continuous supply of high-dose opioid analgesics for chronic pain, (2) overlapping opioid supplies, (3) overlapping opioid and benzodiazepine prescriptions, and (4) prescribing an extended release opioid for an acute pain diagnosis.Results: Provider centrality was associated with reduced incidence of outcome (2) (OR: 0.95) and decreased prevalence of outcomes (1), (2), and (3). However, higher incidence (OR: 1.32) and prevalence (OR: 1.027) of outcome (4) were observed. Conversely, centralization associated with decreased incidence of (1) and (2) and lower prevalence of (1), (2), and (3).Conclusions: Greater provider integration is associated with a lower risk of a provider's patients repeatedly having potentially inappropriate prescription fills; however, the association with a provider having any potentially problematic prescription is more ambiguous.


Assuntos
Analgésicos Opioides/uso terapêutico , Prescrições de Medicamentos/estatística & dados numéricos , Uso de Medicamentos/estatística & dados numéricos , Prescrição Inadequada/estatística & dados numéricos , Padrões de Prática Médica/estatística & dados numéricos , Bases de Dados Factuais , Humanos , Medicaid , Padrões de Prática Médica/tendências , Estados Unidos
10.
Annu Rev Public Health ; 30: 341-55, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-19705561

RESUMO

Setting priorities on the basis of factors such as health impact and economic value is the key first step to ensure that the most important services receive the most attention. Few prioritization efforts have been published that produce either rankings or information that can guide decision making. We propose a framework to help decision makers and clinicians balance short-term demands against long-term objectives. This framework provides guidance for decisions about scope, prioritization criteria, evidence review methods, evaluation of criteria fit, and presentation of results. The framework is the result of our experience setting priorities among clinical preventive services. It has not been tested in prioritizing community interventions and other health care services but should provide a useful starting point for designing priority-setting efforts in those areas.


Assuntos
Prioridades em Saúde , Serviços Preventivos de Saúde , Serviços de Saúde Comunitária/economia , Análise Custo-Benefício , Tomada de Decisões Gerenciais , Prática Clínica Baseada em Evidências , Objetivos , Prioridades em Saúde/economia , Promoção da Saúde , Humanos , Serviços Preventivos de Saúde/economia , Serviços Preventivos de Saúde/métodos , Desenvolvimento de Programas , Estados Unidos
11.
Ann Emerg Med ; 54(4): 514-522.e19, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19716629

RESUMO

STUDY OBJECTIVE: We apply a previously described tool to forecast emergency department (ED) crowding at multiple institutions and assess its generalizability for predicting the near-future waiting count, occupancy level, and boarding count. METHODS: The ForecastED tool was validated with historical data from 5 institutions external to the development site. A sliding-window design separated the data for parameter estimation and forecast validation. Observations were sampled at consecutive 10-minute intervals during 12 months (n=52,560) at 4 sites and 10 months (n=44,064) at the fifth. Three outcome measures-the waiting count, occupancy level, and boarding count-were forecast 2, 4, 6, and 8 hours beyond each observation, and forecasts were compared with observed data at corresponding times. The reliability and calibration were measured following previously described methods. After linear calibration, the forecasting accuracy was measured with the median absolute error. RESULTS: The tool was successfully used for 5 different sites. Its forecasts were more reliable, better calibrated, and more accurate at 2 hours than at 8 hours. The reliability and calibration of the tool were similar between the original development site and external sites; the boarding count was an exception, which was less reliable at 4 of 5 sites. Some variability in accuracy existed among institutions; when forecasting 4 hours into the future, the median absolute error of the waiting count ranged between 0.6 and 3.1 patients, the median absolute error of the occupancy level ranged between 9.0% and 14.5% of beds, and the median absolute error of the boarding count ranged between 0.9 and 2.8 patients. CONCLUSION: The ForecastED tool generated potentially useful forecasts of input and throughput measures of ED crowding at 5 external sites, without modifying the underlying assumptions. Noting the limitation that this was not a real-time validation, ongoing research will focus on integrating the tool with ED information systems.


Assuntos
Ocupação de Leitos , Simulação por Computador , Serviço Hospitalar de Emergência , Listas de Espera , Centros Médicos Acadêmicos , Humanos , Tempo de Internação , Estudos Retrospectivos , Centros de Traumatologia , Estados Unidos
12.
Ann Emerg Med ; 52(5): 504-11, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18313799

RESUMO

STUDY OBJECTIVE: Managers use timestamps from computerized tracking systems to evaluate emergency department (ED) processes. This study was designed to determine how accurately these timestamps reflect the actual ED events they purport to represent. METHODS: An observer manually timestamped patient and provider movement events during all hours. The observed timestamps were then systematically matched to equivalent timestamps collected by an active tracking system (timestamps created by staff with keyboard/mouse) and a passive tracking system (timestamps created by sensor badge worn by staff members). The deviation intervals between the matched timestamps were analyzed. RESULTS: The observer noted a total of 901 events; 686 (76%) of these were successfully matched to active system timestamps and 60 (6.7%) were matched to passive system timestamps. For the active system, the median event was recorded 1.8 minutes before it was observed (interquartile range 30.7 minutes before to 2.9 minutes after). Protocol execution difficulties limited the study of the passive system (low number of successfully matched events). The median event was recorded by the passive system 1.1 minutes before it was observed (interquartile range 1.3 minutes before to 0.9 minutes before) (n=60). CONCLUSION: The timestamps recorded by both active and passive tracking systems contain systematic errors and nonnormal distributions. The active system had much lower precision than the passive system but similar accuracy when large numbers of active system observations were used. Medians should be used to represent timestamp and interval data for reporting purposes. Site-specific data validation should be performed before use of data in high-profile situations.


Assuntos
Serviço Hospitalar de Emergência/estatística & dados numéricos , Garantia da Qualidade dos Cuidados de Saúde/métodos , Estudos de Tempo e Movimento , Computadores , Humanos , Estudos Prospectivos , Reprodutibilidade dos Testes , Fatores de Tempo
13.
Health Serv Res ; 53(6): 4543-4564, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-29845999

RESUMO

OBJECTIVE: Examine how behavioral health (BH) integration affects health care costs, emergency department (ED) visits, and inpatient admissions. DATA SOURCES/STUDY SETTING: Truven Health MarketScan Research Databases. STUDY DESIGN: Social network analysis identified "care communities" (providers sharing a high number of patients) and measured BH integration in terms of how connected, or central, BH providers were to other providers in their community. Multivariable generalized linear models adjusting for age, sex, number of prescriptions, and Charlson comorbidity score were used to estimate the relationship between the centrality of BH providers and health care utilization of BH patients. DATA COLLECTION/EXTRACTION METHODS: Used outpatient, inpatient, and pharmacy claims data from six Medicaid plans from 2011 to 2013 to identify study outcomes, comorbidities, providers, and health care encounters. PRINCIPAL FINDINGS: Behavioral health centrality ranged from 0 (no BH providers) to 0.49. Relative to communities at the median BH centrality (0.06), in 2012, BH patients in communities at the 75th percentile of BH centrality (0.31) had 0.2 fewer admissions, 2.1 fewer all-cause ED visits, and accrued $1,947 fewer costs, on average. CONCLUSIONS: Increased behavioral centrality was significantly associated with a reduced number of ED visits, less frequent inpatient admissions, and lower overall health care costs.


Assuntos
Prestação Integrada de Cuidados de Saúde/estatística & dados numéricos , Custos de Cuidados de Saúde/estatística & dados numéricos , Transtornos Mentais , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Adulto , Idoso , Comorbidade , Bases de Dados Factuais , Serviço Hospitalar de Emergência/estatística & dados numéricos , Feminino , Hospitalização/estatística & dados numéricos , Humanos , Revisão da Utilização de Seguros/estatística & dados numéricos , Masculino , Medicaid/estatística & dados numéricos , Transtornos Mentais/diagnóstico , Transtornos Mentais/terapia , Pessoa de Meia-Idade , Estudos Retrospectivos , Estados Unidos
14.
Clin Toxicol (Phila) ; 45(4): 396-401, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17486481

RESUMO

OBJECTIVE: We compared insulin and glucose (IN/G) to vasopressin plus epinephrine (V/E) in a pig model of beta-blocker toxicity. Primary outcome was survival over four hours. METHODS: Ten pigs received a 0.5 mg/kg bolus of propranolol IV followed by a continuous infusion. At the point of toxicity 20 ml/kg normal saline was rapidly infused and the propranolol drip continued at 0.125 mg/kg/min over four hours of resuscitation. Each pig was randomized to either IN/G or V/E. The V/E group began with epinephrine at 10 mcg/kg/min titrated up by 10 mcg/kg/min every 10 min to 50 mcg/kg/min or until baseline was obtained. Simultaneously, these pigs received vasopressin at 0.0028 units/kg/min, titrated upwards every 10 min to 0.014 units/kg/min or until baseline was obtained. The IN/G group began with a 2 units/kg/hr drip and increased by 2 units every 10 minutes to 10 units/kg/hr, or until baseline hemodynamics were obtained. CO, SVR, systolic blood pressure, HR, MAP, glucose, and potassium were monitored. Glucose was given for values <60 mg/dl. RESULTS: The study was terminated early due to marked survival differences after five pigs were entered in each group. All IN/G group pigs survived four hours. All V/E group pigs died within 90 min. CO in the IN/G group increased throughout the four hours, rising above pre-propranolol levels, while MAP, SBP, and SVR all trended slightly downward. CO in the V/E group dropped until death, while MAP, SBP, and SVR rose precipitously until 30-60 minutes when these dropped abruptly until death. Glucose was required in the IN/G group. CONCLUSION: In this swine model, IN/G is superior to V/E to treat beta-blocker toxicity. IN/G has marked inotropic properties while the vasopressor effects of V/E depress CO and contribute to death. Increasing SVR in this condition is detrimental to survival.


Assuntos
Agonistas Adrenérgicos beta/uso terapêutico , Antagonistas Adrenérgicos beta/intoxicação , Epinefrina/uso terapêutico , Hipoglicemiantes/uso terapêutico , Insulina/uso terapêutico , Propranolol/intoxicação , Vasoconstritores/uso terapêutico , Vasopressinas/uso terapêutico , Animais , Pressão Sanguínea/efeitos dos fármacos , Débito Cardíaco/efeitos dos fármacos , Quimioterapia Combinada , Determinação de Ponto Final , Glucose/uso terapêutico , Frequência Cardíaca/efeitos dos fármacos , Concentração de Íons de Hidrogênio , Análise de Sobrevida , Suínos , Resistência Vascular/efeitos dos fármacos
15.
Minn Med ; 90(9): 40-3, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17966263

RESUMO

In order to explore the correlation between physical activity, fitness, and injury among police officers, a cross section of active-duty members of the Minneapolis Police Department were surveyed about their level of fitness, physical activity, and prevalence of injury and chronic pain within the past year. In the study, officers with the highest self-reported fitness levels were less likely to experience sprains (OR 0.27, 95% CI 0.08-0.88), back pain (OR 0.48, 95% CI 0.09-0.88), and chronic pain (OR 0.21, 95% CI 0.06-0.73) than those who considered themselves less fit. Officers who were the most physically active were about a third as likely to report back pain (OR 0.37, 95% CI 0.10-0.73) and less than half as likely to report chronic pain (OR 0.42, 95% CI 0.19-0.91) as those who engaged in less activity. And officers with a BMI greater than 35 were 3 times more likely to report back pain (OR 3.36, 95% CI 1.17-9.66) than those whose BMI fell in the normal range (18-25). Thus, officers who engage in higher levels of physical activity and are more physically fit have a lower prevalence of musculoskeletal injuries and chronic pain.


Assuntos
Acidentes de Trabalho/estatística & dados numéricos , Exercício Físico , Sistema Musculoesquelético/lesões , Aptidão Física , Polícia , Adulto , Dor nas Costas/epidemiologia , Índice de Massa Corporal , Doença Crônica , Estudos Transversais , Feminino , Inquéritos Epidemiológicos , Humanos , Masculino , Minnesota , Obesidade/epidemiologia , Dor/epidemiologia , Estatística como Assunto
16.
Acad Emerg Med ; 24(4): 447-457, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-27992953

RESUMO

OBJECTIVE: In 2006, the American College of Surgeons' Committee on Trauma and the Centers for Disease Control and Prevention released field triage guidelines with special consideration for older adults. Additional considerations for direct transport to a Level I or II trauma center (TC) were added in 2011, reflecting perceived undertriage to TCs for older adults. We examined whether age-based disparities in TC care for severe head injury decreased following introduction of the 2011 revisions. METHODS: A pre-post design analyzing the 2009 and 2012 Healthcare Cost and Utilization Project State Emergency Department Databases and State Inpatient Databases with multivariable logistic regressions considered changes in 1) the trauma designation of the emergency department where treatment was initiated and 2) transfer to a TC following initial treatment at a non-TC. RESULTS: Compared with adults aged 18 to 44 years, after multivariable adjustment, in both years TC care was less likely for adults aged 45 to 64 years (odds ratio [OR] = 0.76 in 2009 and 0.74 in 2012), aged 65 to 84 years (OR = 0.61 and 0.59), and aged 85+ years (OR = 0.53 and 0.56). Between 2009 and 2012, the likelihood of TC care increased for all age groups, with the largest increase among those aged 85+ years (OR = 1.18), which was statistically different (p = 0.02) from the increase among adults aged 18 to 44 years (OR = 1.12). The analysis of transfers yielded similar results. CONCLUSIONS: Although patterns of increased TC treatment for all groups with severe head trauma indicate improvements, age-based disparities persisted.


Assuntos
Fatores Etários , Serviço Hospitalar de Emergência/estatística & dados numéricos , Disparidades em Assistência à Saúde , Transferência de Pacientes/estatística & dados numéricos , Centros de Traumatologia/normas , Triagem/normas , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Traumatismos Craniocerebrais/terapia , Bases de Dados Factuais , Feminino , Humanos , Modelos Logísticos , Pessoa de Meia-Idade , Razão de Chances , Guias de Prática Clínica como Assunto , Estados Unidos , Adulto Jovem
17.
Am J Prev Med ; 31(1): 52-61, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16777543

RESUMO

BACKGROUND: Decision makers at multiple levels need information about which clinical preventive services matter the most so that they can prioritize their actions. This study was designed to produce comparable estimates of relative health impact and cost effectiveness for services considered effective by the U.S. Preventive Services Task Force and Advisory Committee on Immunization Practices. METHODS: The National Commission on Prevention Priorities (NCPP) guided this update to a 2001 ranking of clinical preventive services. The NCPP used new preventive service recommendations up to December 2004, improved methods, and more complete and recent data and evidence. Each service received 1 to 5 points on each of two measures--clinically preventable burden and cost effectiveness--for a total score ranging from 2 to 10. Priorities for improving delivery rates were established by comparing the ranking with what is known of current delivery rates nationally. RESULTS: The three highest-ranking services each with a total score of 10 are discussing aspirin use with high-risk adults, immunizing children, and tobacco-use screening and brief intervention. High-ranking services (scores of 6 and above) with data indicating low current utilization rates (around 50% or lower) include: tobacco-use screening and brief intervention, screening adults aged 50 and older for colorectal cancer, immunizing adults aged 65 and older against pneumococcal disease, and screening young women for Chlamydia. CONCLUSION: This study identifies the most valuable clinical preventive services that can be offered in medical practice and should help decision-makers select which services to emphasize.


Assuntos
Prioridades em Saúde , Serviços Preventivos de Saúde/estatística & dados numéricos , Anos de Vida Ajustados por Qualidade de Vida , Adulto , Anti-Inflamatórios não Esteroides/uso terapêutico , Aspirina/uso terapêutico , Doenças Cardiovasculares/prevenção & controle , Análise Custo-Benefício , Tomada de Decisões , Feminino , Humanos , Programas de Imunização , Masculino , Pessoa de Meia-Idade , Serviços Preventivos de Saúde/classificação , Serviços Preventivos de Saúde/economia , Estados Unidos
18.
Am J Prev Med ; 31(1): 90-6, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16777547

RESUMO

Decision makers want to know which healthcare services matter the most, but there are no well-established, practical methods for providing evidence-based answers to such questions. Led by the National Commission on Prevention Priorities, the authors update the methods for determining the relative health impact and economic value of clinical preventive services. Using new studies, new preventive service recommendations, and improved methods, the authors present a new ranking of clinical preventive services in the companion article. The original ranking and methods were published in this journal in 2001. The current methods report focuses on evidence collection for a priority setting exercise, guidance for which is effectively lacking in the literature. The authors describe their own standards for searching, tracking, and abstracting literature for priority setting. The authors also summarize their methods for making valid comparisons across different services. This report should be useful to those who want to understand additional detail about how the ranking was developed or who want to adapt the methods for their own purposes.


Assuntos
Análise Custo-Benefício , Prioridades em Saúde , Serviços Preventivos de Saúde/normas , Humanos , Serviços Preventivos de Saúde/classificação , Serviços Preventivos de Saúde/economia , Anos de Vida Ajustados por Qualidade de Vida
19.
J Am Board Fam Med ; 29(4): 482-95, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27390380

RESUMO

BACKGROUND: Research connecting patient-centered medical homes (PCMHs) with improved quality and reduced utilization is inconsistent, possibly because individual domains of change, and the stage of change, are not incorporated in the research design. The objective of this study was to examine the association between stage and domain of change and patterns of health care utilization. METHODS: This was a cross-sectional observational study that including 87 Minnesota clinics certified as medical homes. Patients included those receiving management for diabetes or cardiovascular disease with insurance coverage by payers participating in the study. PCMH transformation stage was defined by practice systems in place, with measurements summarized in 5 domains. Health care utilization was measured by total utilization, frequency of outpatient visits and prescriptions, and occurrence of inpatient and emergency department visits. RESULTS: PCMH transformation was associated with few changes in utilization, but there were important differences by the underlying domains of change. We demonstrate meaningful differences in the impact of PCMH transformation by diagnosis cohort and comorbidity status of the patient. CONCLUSIONS: Because the association of health care utilization with PCMH transformation varied by transformation domain and patient diagnosis, practice leaders need to be supported by research incorporating detailed measures of PCMH transformation.


Assuntos
Doenças Cardiovasculares/terapia , Diabetes Mellitus/terapia , Aceitação pelo Paciente de Cuidados de Saúde/estatística & dados numéricos , Assistência Centrada no Paciente/estatística & dados numéricos , Adulto , Idoso , Assistência Ambulatorial/estatística & dados numéricos , Doenças Cardiovasculares/epidemiologia , Doença Crônica , Comorbidade , Estudos Transversais , Diabetes Mellitus/epidemiologia , Prescrições de Medicamentos/estatística & dados numéricos , Serviço Hospitalar de Emergência/estatística & dados numéricos , Feminino , Custos de Cuidados de Saúde , Hospitalização/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Minnesota , Assistência Centrada no Paciente/economia , Melhoria de Qualidade , Projetos de Pesquisa
20.
Am J Prev Med ; 50(5 Suppl 1): S34-S44, 2016 05.
Artigo em Inglês | MEDLINE | ID: mdl-27102856

RESUMO

INTRODUCTION: Team-based interventions for hypertension care have been widely studied and shown effective in improving hypertension outcomes. Few studies have evaluated long-term effects of these interventions; none have assessed broad-scale implementation. This study estimates the prospective health, economic, and budgetary impact of universal adoption of a team-based care intervention model that targets people with treated but uncontrolled hypertension in the U.S. METHODS: Analysis was conducted in 2014-2015 using a microsimulation model, constructed with various data sources from 1948 to 2014, designed to evaluate prospective cardiovascular disease (CVD)-related interventions in the U.S. POPULATION: Ten-year primary outcomes included prevalence of uncontrolled hypertension; incident myocardial infarction, stroke, CVD events, and CVD-related mortality; intervention and net medical costs by payer; productivity; and quality-adjusted life years. RESULTS: About 4.7 million (13%) fewer people with uncontrolled hypertension and 638,000 prevented cardiovascular events would be expected over 10 years. Assuming $525 per enrollee, implementation would cost payers $22.9 billion, but $25.3 billion would be saved in averted medical costs. Estimated net cost savings for Medicare approached $5.8 billion. Net costs were especially sensitive to intervention costs, with break-even thresholds of $300 (private), $450 (Medicaid), and $750 (Medicare). CONCLUSIONS: Nationwide adoption of team-based care for uncontrolled hypertension could have sizable effects in reducing CVD burden. Based on the study's assumptions, the policy would be cost saving from the perspective of Medicare and may prove to be cost effective from other payers' perspectives. Expected net cost savings for Medicare would more than offset expected net costs for all other insurers.


Assuntos
Análise Custo-Benefício , Hipertensão/economia , Modelos Econômicos , Equipe de Assistência ao Paciente , Doenças Cardiovasculares/economia , Doenças Cardiovasculares/epidemiologia , Doenças Cardiovasculares/prevenção & controle , Custos de Cuidados de Saúde , Humanos , Hipertensão/terapia , Estudos Prospectivos , Anos de Vida Ajustados por Qualidade de Vida , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa